Folgen
David Moher
David Moher
Ottawa Hospital Research Institute
Bestätigte E-Mail-Adresse bei ohri.ca
Titel
Zitiert von
Zitiert von
Jahr
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
D Moher, A Liberati, J Tetzlaff, DG Altman, t PRISMA Group*
Annals of internal medicine 151 (4), 264-269, 2009
165896*2009
Cochrane handbook for systematic reviews of interventions
JPT Higgins, S Green
Wiley-Blackwell 5 (2), S38, 2008
668232008
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
MJ Page, JE McKenzie, PM Bossuyt, I Boutron, TC Hoffmann, CD Mulrow, ...
Bmj 372, 2021
532902021
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
A Liberati, DG Altman, J Tetzlaff, C Mulrow, PC Gøtzsche, JPA Ioannidis, ...
Annals of internal medicine 151 (4), W-65-W-94, 2009
495692009
The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials
JPT Higgins, DG Altman, PC Gøtzsche, P Jüni, D Moher, AD Oxman, ...
Bmj 343, 2011
281712011
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement
D Moher, L Shamseer, M Clarke, D Ghersi, A Liberati, M Petticrew, ...
Systematic reviews 4, 1-9, 2015
207232015
Meta-analysis of observational studies in epidemiology: a proposal for reporting
DF Stroup, JA Berlin, SC Morton, I Olkin, GD Williamson, D Rennie, ...
Jama 283 (15), 2008-2012, 2000
205962000
PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation
AC Tricco, E Lillie, W Zarin, KK O'Brien, H Colquhoun, D Levac, D Moher, ...
Annals of internal medicine 169 (7), 467-473, 2018
193402018
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation
L Shamseer, D Moher, M Clarke, D Ghersi, A Liberati, M Petticrew, ...
Bmj 349, 2015
114822015
The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials
D Moher, KF Schulz, DG Altman
The lancet 357 (9263), 1191-1194, 2001
10715*2001
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration
JP Vandenbroucke, E Elm, DG Altman, PC Gøtzsche, CD Mulrow, ...
Annals of internal medicine 147 (8), W-163-W-194, 2007
93832007
Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide
TC Hoffmann, PP Glasziou, I Boutron, R Milne, R Perera, D Moher, ...
Bmj 348, 2014
74462014
AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both
BJ Shea, BC Reeves, G Wells, M Thuku, C Hamel, J Moran, D Moher, ...
bmj 358, 2017
72532017
Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement
D Moher, DJ Cook, S Eastwood, I Olkin, D Rennie, DF Stroup
The Lancet 354 (9193), 1896-1900, 1999
60051999
SPIRIT 2013 statement: defining standard protocol items for clinical trials
AW Chan, JM Tetzlaff, DG Altman, A Laupacis, PC Gøtzsche, ...
Annals of internal medicine 158 (3), 200-207, 2013
57612013
Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials
JAC Sterne, AJ Sutton, JPA Ioannidis, N Terrin, DR Jones, J Lau, ...
Bmj 343, 2011
56992011
The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations
B Hutton, G Salanti, DM Caldwell, A Chaimani, CH Schmid, C Cameron, ...
Annals of internal medicine 162 (11), 777-784, 2015
53232015
Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews
BJ Shea, JM Grimshaw, GA Wells, M Boers, N Andersson, C Hamel, ...
BMC medical research methodology 7, 1-7, 2007
51222007
Improving the quality of reporting of randomized controlled trials: the CONSORT statement
C Begg, M Cho, S Eastwood, R Horton, D Moher, I Olkin, R Pitkin, ...
Jama 276 (8), 637-639, 1996
47871996
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
AW Chan, JM Tetzlaff, PC Gøtzsche, DG Altman, H Mann, JA Berlin, ...
Bmj 346, 2013
47002013
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20